The effectiveness of Lipitor (atorvastatin) in reducing both protein and cholesterol levels has been extensively studied, but its impact on protein is relatively minimal [1]. Lipitor primarily works by inhibiting the HMG-CoA reductase enzyme in the liver, which leads to a decrease in low-density lipoprotein (LDL) or "bad" cholesterol production [2].

Research has shown that atorvastatin does have a slight effect on triglyceride levels, which are a type of fat found in the blood, but its impact on protein is not significant [3]. The primary clinical benefit of Lipitor lies in its ability to significantly reduce LDL cholesterol levels, leading to improved cardiovascular outcomes for patients at risk.

For instance, a study examining the effects of atorvastatin on various lipid and protein parameters found that at moderate to high doses, the medication reduced LDL cholesterol by approximately 40-60%, but did not demonstrate a significant impact on albuminuria or proteinuria, which are markers of potential kidney damage [4].

According to the prescribing information, Lipitor is indicated to reduce the risk of cardiovascular events in patients with or at risk of coronary heart disease [5]. However, it's essential to note that patients with specific conditions, such as diabetes or kidney disease, may require careful monitoring to ensure safe and effective use of the medication.

Overall, Lipitor's primary mechanism of action focuses on cholesterol reduction, while its effects on protein are relatively minimal. As always, the benefits and risks of any medication should be discussed with a healthcare professional to determine the best course of treatment.

Sources:

[1] https://www.drugpatentwatch.com/patent/US20040259053 - [2] https://www.drugbank.ca/drugs/DB01129 - [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211430/ - [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211430/ - [5] https://www.drugbank.ca/drugs/DB01129